MOMETASONE

MOMETASONE was reported 42729 times

MOMETASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CFTR GENE MUTATION 20 0.8000
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 126 0.7039
2 HEART SOUNDS 38 0.3958
3 EJECTION FRACTION 213 0.3666
4 SENSITISATION 270 0.3557
5 TOPICAL STEROID WITHDRAWAL REACTION 132 0.3393
6 POLYCYSTIC OVARIES 272 0.1753
7 PROLONGED EXPIRATION 39 0.1489
8 ANAL PROLAPSE 16 0.1356
9 OBSTRUCTIVE SLEEP APNOEA SYNDROME 186 0.1275
10 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 111 0.1197
11 DUST ALLERGY 114 0.1162
12 SPIROMETRY ABNORMAL 60 0.1003
13 MITE ALLERGY 64 0.0977
14 CONGENITAL HIATUS HERNIA 19 0.0833
15 MYOGLOBIN BLOOD INCREASED 127 0.0830
16 EJECTION FRACTION ABNORMAL 99 0.0808
17 PULMONARY VASCULITIS 43 0.0799
18 ALVEOLAR OSTEITIS 33 0.0780
19 MYCOTIC ALLERGY 66 0.0772
20 STEROID WITHDRAWAL SYNDROME 75 0.0734
21 RHINITIS ALLERGIC 321 0.0720
22 URINARY TRACT DISCOMFORT 33 0.0716
23 BREAST CONSERVING SURGERY 31 0.0605
24 NEPHRECTOMY 88 0.0592
25 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 119 0.0583
26 TOTAL LUNG CAPACITY ABNORMAL 20 0.0514
27 ALLERGY TO ANIMAL 51 0.0478
28 ADRENAL SUPPRESSION 39 0.0463
29 FULL BLOOD COUNT ABNORMAL 458 0.0433
30 CONJUNCTIVITIS ALLERGIC 64 0.0432
31 BRAIN NATRIURETIC PEPTIDE INCREASED 128 0.0415
32 SKIN WEEPING 144 0.0403
33 ANIMAL SCRATCH 39 0.0401
34 PLANTAR FASCIITIS 133 0.0396
35 PNEUMOCOCCAL INFECTION 23 0.0389
36 OBSTRUCTIVE AIRWAYS DISORDER 428 0.0384
37 BRONCHIAL OBSTRUCTION 54 0.0384
38 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 639 0.0376
39 TOTAL LUNG CAPACITY DECREASED 59 0.0369
40 VACCINATION SITE PAIN 21 0.0365
41 LUNG OPACITY 89 0.0337
42 ADENOMA BENIGN 28 0.0326
43 ECZEMA HERPETICUM 15 0.0324
44 PLEURITIC PAIN 89 0.0322
45 NEURITIS 45 0.0291
46 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 21 0.0286
47 ENTEROCOLITIS INFECTIOUS 26 0.0282
48 BRONCHIAL WALL THICKENING 20 0.0278
49 BLOOD TEST ABNORMAL 371 0.0264
50 NASAL POLYPS 128 0.0260
51 PANCREATITIS RELAPSING 21 0.0257
52 DERMATOSIS 16 0.0256
53 TEMPERATURE REGULATION DISORDER 57 0.0256
54 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 65 0.0244
55 RALES 138 0.0237
56 LIP PRURITUS 20 0.0233
57 ALLERGIC SINUSITIS 20 0.0233
58 RESPIRATORY SYMPTOM 66 0.0232
59 SPUTUM DISCOLOURED 213 0.0224
60 CERUMEN IMPACTION 20 0.0218
61 FORCED EXPIRATORY VOLUME DECREASED 61 0.0215
62 SINUS PAIN 50 0.0214
63 TUNNEL VISION 40 0.0213
64 CARPAL TUNNEL SYNDROME 294 0.0210
65 ACQUIRED HAEMOPHILIA 21 0.0210
66 SLEEP APNOEA SYNDROME 396 0.0207
67 SEBORRHOEIC KERATOSIS 29 0.0200
68 NORMOCHROMIC NORMOCYTIC ANAEMIA 60 0.0200
69 CHRONIC SPONTANEOUS URTICARIA 23 0.0198
70 ENTHESOPATHY 31 0.0198
71 FIBROMA 18 0.0196
72 BRONCHIECTASIS 132 0.0196
73 RENAL NEOPLASM 41 0.0193
74 WHEEZING 1042 0.0176
75 TENOSYNOVITIS 48 0.0174
76 PARANASAL SINUS DISCOMFORT 64 0.0169
77 SENSATION OF FOREIGN BODY 138 0.0164
78 SKIN WRINKLING 44 0.0162
79 BLOOD PRESSURE DIASTOLIC ABNORMAL 40 0.0157
80 CATAPLEXY 22 0.0155
81 EAR CONGESTION 42 0.0155
82 BLADDER TRANSITIONAL CELL CARCINOMA 22 0.0154
83 CALCULUS URINARY 23 0.0149
84 ASTHMA 1665 0.0147
85 INCREASED UPPER AIRWAY SECRETION 75 0.0146
86 EXOSTOSIS 131 0.0143
87 MAST CELL ACTIVATION SYNDROME 20 0.0142
88 SECRETION DISCHARGE 171 0.0136
89 RHINITIS 110 0.0136
90 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21 0.0131
91 FIBROMYALGIA 317 0.0130
92 INCREASED BRONCHIAL SECRETION 33 0.0129
93 VENTRICULAR HYPERTROPHY 32 0.0127
94 PRODUCT DELIVERY MECHANISM ISSUE 68 0.0126
95 GASTROOESOPHAGEAL REFLUX DISEASE 1017 0.0126
96 SKIN ATROPHY 72 0.0125
97 DEPRESSIVE SYMPTOM 43 0.0122
98 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 585 0.0122
99 EOSINOPHILIA 212 0.0121
100 POLYMYALGIA RHEUMATICA 38 0.0119
101 LICHENOID KERATOSIS 27 0.0118
102 OBSTRUCTION 47 0.0118
103 WOUND SECRETION 46 0.0117
104 CHRONIC SINUSITIS 44 0.0117
105 EOSINOPHIL COUNT INCREASED 97 0.0116
106 BODY TEMPERATURE FLUCTUATION 24 0.0115
107 SWOLLEN TONGUE 358 0.0115
108 HYPOTHYROIDISM 366 0.0114
109 UPPER-AIRWAY COUGH SYNDROME 94 0.0114
110 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 794 0.0112
111 VASCULITIS 130 0.0111
112 NASAL OEDEMA 20 0.0111
113 PNEUMONIA ASPIRATION 270 0.0108
114 ADRENOCORTICAL INSUFFICIENCY ACUTE 21 0.0108
115 BLADDER PAIN 34 0.0107
116 WOUND COMPLICATION 36 0.0105
117 CLOSTRIDIUM TEST POSITIVE 23 0.0104
118 PRE-EXISTING CONDITION IMPROVED 64 0.0102
119 NASAL SEPTUM DEVIATION 20 0.0102
120 PRODUCTIVE COUGH 479 0.0100
121 ARTERIOSCLEROSIS CORONARY ARTERY 66 0.0100
122 NEPHROGENIC ANAEMIA 46 0.0099
123 PHARYNGEAL ERYTHEMA 21 0.0099
124 JOINT NOISE 19 0.0097
125 NEUROLOGICAL SYMPTOM 55 0.0096
126 FOREIGN BODY IN THROAT 30 0.0095
127 DYSPNOEA EXERTIONAL 348 0.0092
128 RESPIRATION ABNORMAL 63 0.0091
129 SNORING 34 0.0090
130 LIPOMA 23 0.0089
131 SEASONAL ALLERGY 122 0.0086
132 SKIN PLAQUE 72 0.0085
133 SKIN DISCOMFORT 23 0.0085
134 RHINALGIA 23 0.0084
135 BLOOD CALCIUM INCREASED 73 0.0083
136 THROAT CLEARING 31 0.0083
137 SINUS DISORDER 162 0.0082
138 ANGIOEDEMA 360 0.0081
139 DYSPHONIA 471 0.0080
140 PULMONARY ALVEOLAR HAEMORRHAGE 45 0.0080
141 PUSTULE 19 0.0080
142 PANCREATIC CYST 15 0.0078
143 MASTICATION DISORDER 24 0.0078
144 SKIN FRAGILITY 19 0.0078
145 DERMATITIS EXFOLIATIVE GENERALISED 27 0.0078
146 ASPIRATION 85 0.0078
147 ASTHMATIC CRISIS 28 0.0077
148 ARTERIOSCLEROSIS 72 0.0076
149 FOOD ALLERGY 59 0.0076
150 THROMBOPHLEBITIS SUPERFICIAL 23 0.0076
151 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 41 0.0075
152 MELANOCYTIC NAEVUS 33 0.0075
153 HYPOPNOEA 26 0.0075
154 PNEUMOTHORAX 118 0.0074
155 PAPULE 52 0.0074
156 HAEMANGIOMA 17 0.0073
157 HAEMOPTYSIS 205 0.0073
158 EXERCISE TOLERANCE DECREASED 42 0.0073
159 HYPERPARATHYROIDISM SECONDARY 18 0.0072
160 VARICOSE VEIN 37 0.0072
161 APPETITE DISORDER 47 0.0071
162 EAR SWELLING 15 0.0071
163 INFUSION SITE BRUISING 15 0.0069
164 ACTINIC KERATOSIS 18 0.0069
165 TYPE 2 DIABETES MELLITUS 233 0.0069
166 LICHEN PLANUS 16 0.0069
167 BLOOD PRESSURE SYSTOLIC ABNORMAL 17 0.0069
168 SWELLING FACE 445 0.0068
169 UPPER RESPIRATORY TRACT INFECTION 315 0.0068
170 BONE EROSION 24 0.0068
171 BENIGN PROSTATIC HYPERPLASIA 35 0.0068
172 POST-TRAUMATIC STRESS DISORDER 45 0.0067
173 CHRONIC GASTRITIS 15 0.0066
174 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 43 0.0066
175 APHTHOUS ULCER 51 0.0066
176 RENAL CELL CARCINOMA 32 0.0065
177 SYMPTOM RECURRENCE 39 0.0065
178 WOUND HAEMORRHAGE 24 0.0065
179 PULMONARY FIBROSIS 124 0.0065
180 BLOOD COUNT ABNORMAL 98 0.0065
181 HYPERAESTHESIA 53 0.0064
182 FUNGAL SKIN INFECTION 26 0.0064
183 NODULE 84 0.0064
184 BRONCHOSPASM 91 0.0064
185 ADRENAL INSUFFICIENCY 77 0.0063
186 RESPIRATORY TRACT CONGESTION 100 0.0063
187 BREATH SOUNDS ABNORMAL 31 0.0063
188 BLOOD PRESSURE DIASTOLIC INCREASED 29 0.0063
189 MIDDLE INSOMNIA 117 0.0063
190 KERATITIS 19 0.0062
191 ROSACEA 29 0.0062
192 DYSPNOEA AT REST 18 0.0062
193 MENOPAUSE 16 0.0062
194 BLOOD PRESSURE SYSTOLIC INCREASED 120 0.0061
195 SINUS CONGESTION 83 0.0061
196 ECZEMA 321 0.0061
197 GROWTH RETARDATION 18 0.0061
198 SKIN HYPERTROPHY 17 0.0060
199 CORONARY ARTERY DISEASE 182 0.0060
200 BURNING SENSATION 420 0.0060
201 BLEPHARITIS 24 0.0060
202 HYPERURICAEMIA 24 0.0058
203 RENAL CYST 46 0.0058
204 IRON DEFICIENCY 26 0.0058
205 NASAL CONGESTION 338 0.0057
206 PRODUCT ADMINISTRATION INTERRUPTED 45 0.0057
207 INFUSION SITE REACTION 17 0.0057
208 SARCOIDOSIS 27 0.0057
209 NEPHROPATHY 53 0.0057
210 NASAL DISORDER 15 0.0056
211 CARDIAC DISORDER 527 0.0056
212 RENAL DISORDER 262 0.0056
213 LOWER RESPIRATORY TRACT INFECTION 255 0.0056
214 FLANK PAIN 52 0.0055
215 SKIN INFECTION 62 0.0055
216 ATRIAL FLUTTER 44 0.0055
217 FUNCTIONAL GASTROINTESTINAL DISORDER 19 0.0055
218 LEFT VENTRICULAR HYPERTROPHY 23 0.0054
219 ELECTRIC SHOCK SENSATION 15 0.0054
220 IMPAIRED QUALITY OF LIFE 77 0.0054
221 DERMATITIS ATOPIC 280 0.0053
222 EAR PAIN 102 0.0052
223 MYOPATHY 45 0.0052
224 CHEST DISCOMFORT 530 0.0052
225 DEAFNESS NEUROSENSORY 17 0.0052
226 EAR DISCOMFORT 53 0.0052
227 PSEUDOMONAS INFECTION 44 0.0051
228 SKIN SWELLING 44 0.0051
229 SKIN LACERATION 55 0.0051
230 COMA 240 0.0050
231 CUSHINGOID 16 0.0050
232 HYPOXIA 174 0.0049
233 PULMONARY MASS 73 0.0049
234 BODY TEMPERATURE DECREASED 48 0.0049
235 SKIN ABRASION 23 0.0049
236 ATELECTASIS 47 0.0049
237 BURSITIS 59 0.0049
238 ERYTHEMA NODOSUM 17 0.0048
239 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 83 0.0048
240 LIVER FUNCTION TEST INCREASED 103 0.0048
241 ERYSIPELAS 24 0.0048
242 SKIN FISSURES 93 0.0048
243 INFUSION SITE PRURITUS 15 0.0047
244 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
245 SKIN EXFOLIATION 397 0.0047
246 PHARYNGEAL SWELLING 46 0.0047
247 SINUSITIS 480 0.0047
248 DERMATITIS CONTACT 53 0.0046
249 MICTURITION URGENCY 53 0.0046
250 DRUG INTOLERANCE 448 0.0046
251 ATRIOVENTRICULAR BLOCK FIRST DEGREE 20 0.0046
252 HYPERGLYCAEMIA 168 0.0046
253 COUGH 1276 0.0045
254 CONJUNCTIVITIS 84 0.0045
255 ECCHYMOSIS 31 0.0045
256 ANXIETY DISORDER 15 0.0045
257 BLOOD IRON DECREASED 53 0.0045
258 MULTIPLE ALLERGIES 35 0.0045
259 INGUINAL HERNIA 27 0.0044
260 PHARYNGITIS 55 0.0044
261 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 243 0.0044
262 SKIN HYPERPIGMENTATION 38 0.0044
263 GLUCOSE TOLERANCE IMPAIRED 26 0.0044
264 SLEEP DISORDER 310 0.0044
265 FAECALOMA 24 0.0044
266 EAR DISORDER 20 0.0044
267 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
268 INTERVERTEBRAL DISC DEGENERATION 40 0.0043
269 SKIN ODOUR ABNORMAL 17 0.0043
270 TENDERNESS 45 0.0043
271 OBESITY 68 0.0043
272 SOMNAMBULISM 28 0.0043
273 FOREIGN BODY SENSATION IN EYES 27 0.0042
274 RHINORRHOEA 273 0.0042
275 GASTROENTERITIS 61 0.0042
276 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218 0.0042
277 SCRATCH 44 0.0042
278 ABDOMINAL HERNIA 19 0.0042
279 PERIPHERAL VENOUS DISEASE 17 0.0042
280 NASAL DISCOMFORT 33 0.0042
281 HYPERCHOLESTEROLAEMIA 40 0.0041
282 DERMATITIS ALLERGIC 52 0.0041
283 LUNG DISORDER 202 0.0041
284 UTERINE LEIOMYOMA 30 0.0041
285 NEURALGIA 99 0.0041
286 HYPERSENSITIVITY 751 0.0040
287 PYELONEPHRITIS 35 0.0040
288 SKIN TIGHTNESS 19 0.0040
289 VIRAL UPPER RESPIRATORY TRACT INFECTION 19 0.0040
290 KLEBSIELLA INFECTION 20 0.0040
291 HIDRADENITIS 36 0.0039
292 SKIN HAEMORRHAGE 58 0.0039
293 DIVERTICULUM INTESTINAL 17 0.0039
294 ERYTHEMA OF EYELID 21 0.0039
295 TEMPERATURE INTOLERANCE 40 0.0039
296 BASAL CELL CARCINOMA 60 0.0038
297 WRIST FRACTURE 46 0.0038
298 RESPIRATORY RATE INCREASED 34 0.0038
299 WHEELCHAIR USER 17 0.0038
300 INFUSION SITE SWELLING 24 0.0038
301 BRONCHITIS 282 0.0038
302 ATTENTION DEFICIT HYPERACTIVITY DISORDER 16 0.0038
303 CYSTIC FIBROSIS 21 0.0038
304 DERMATITIS 79 0.0038
305 HYPERLIPIDAEMIA 45 0.0038
306 RESPIRATORY TRACT INFECTION 98 0.0038
307 IMPAIRED GASTRIC EMPTYING 51 0.0037
308 PERIORBITAL SWELLING 21 0.0037
309 ISCHAEMIA 17 0.0037
310 DYSURIA 135 0.0037
311 PULMONARY FUNCTION TEST DECREASED 16 0.0037
312 HYPERVENTILATION 21 0.0036
313 SENSITIVITY TO WEATHER CHANGE 19 0.0036
314 OSTEOARTHRITIS 152 0.0036
315 CLOSTRIDIUM DIFFICILE COLITIS 38 0.0036
316 JOINT INJURY 76 0.0036
317 SKIN LESION 97 0.0035
318 OROPHARYNGEAL PAIN 327 0.0035
319 INCORRECT DRUG ADMINISTRATION RATE 15 0.0035
320 THERMAL BURN 25 0.0035
321 TRANSAMINASES INCREASED 78 0.0035
322 QUALITY OF LIFE DECREASED 47 0.0035
323 ORAL CANDIDIASIS 46 0.0035
324 POOR VENOUS ACCESS 36 0.0035
325 END STAGE RENAL DISEASE 63 0.0035
326 ANAL INCONTINENCE 31 0.0034
327 PAROSMIA 26 0.0034
328 OROPHARYNGEAL DISCOMFORT 31 0.0034
329 PSORIATIC ARTHROPATHY 137 0.0034
330 BLOOD PRESSURE FLUCTUATION 81 0.0034
331 OSTEOPENIA 51 0.0034
332 NASAL DRYNESS 21 0.0033
333 DYSPNOEA 1881 0.0033
334 PHLEBITIS 17 0.0033
335 THERAPEUTIC RESPONSE SHORTENED 110 0.0033
336 HYPERTENSION 701 0.0033
337 LIMB INJURY 89 0.0033
338 VENTRICULAR EXTRASYSTOLES 34 0.0033
339 RASH ERYTHEMATOUS 156 0.0033
340 PULMONARY CONGESTION 43 0.0033
341 RASH PRURITIC 176 0.0032
342 ANOSMIA 47 0.0032
343 BODY TEMPERATURE INCREASED 66 0.0032
344 IMMUNODEFICIENCY 48 0.0032
345 INITIAL INSOMNIA 33 0.0032
346 RASH MACULAR 112 0.0032
347 SWELLING OF EYELID 20 0.0032
348 RESPIRATORY DISORDER 95 0.0032
349 BACTERIAL INFECTION 59 0.0032
350 NASOPHARYNGITIS 582 0.0032
351 VENTRICULAR SEPTAL DEFECT 18 0.0031
352 LIGAMENT SPRAIN 31 0.0031
353 BIPOLAR DISORDER 34 0.0031
354 ERYTHEMA MULTIFORME 29 0.0031
355 ARTHROPOD BITE 23 0.0031
356 MEDICATION ERROR 172 0.0031
357 DEAFNESS UNILATERAL 17 0.0031
358 EAR INFECTION 82 0.0031
359 ATRIAL FIBRILLATION 299 0.0031
360 GOUT 55 0.0031
361 SNEEZING 68 0.0030
362 HYPOKINESIA 44 0.0030
363 DISEASE RECURRENCE 144 0.0030
364 ABDOMINAL TENDERNESS 15 0.0030
365 HIATUS HERNIA 39 0.0030
366 CARDIAC MURMUR 26 0.0030
367 BLOOD URINE PRESENT 57 0.0030
368 LYMPHADENOPATHY 106 0.0030
369 LEFT VENTRICULAR DYSFUNCTION 20 0.0030
370 SCAB 34 0.0030
371 DECREASED ACTIVITY 32 0.0030
372 MENISCUS INJURY 18 0.0029
373 SUPRAVENTRICULAR TACHYCARDIA 28 0.0029
374 SKIN WARM 17 0.0029
375 CHRONIC KIDNEY DISEASE 222 0.0029
376 PIGMENTATION DISORDER 18 0.0029
377 LACRIMATION INCREASED 88 0.0029
378 PLEURAL EFFUSION 177 0.0029
379 TENDONITIS 45 0.0029
380 FOETAL DEATH 15 0.0029
381 RASH PUSTULAR 21 0.0029
382 DECREASED INTEREST 17 0.0029
383 PSORIASIS 376 0.0029
384 SARS-COV-2 TEST POSITIVE 38 0.0029
385 FEELING COLD 80 0.0029
386 PROCEDURAL PAIN 79 0.0028
387 PANIC ATTACK 103 0.0028
388 HEAD DISCOMFORT 50 0.0028
389 IMMUNE SYSTEM DISORDER 37 0.0028
390 SENSORY DISTURBANCE 45 0.0028
391 BLISTER 156 0.0028
392 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
393 MUSCULOSKELETAL STIFFNESS 242 0.0028
394 INFLUENZA 308 0.0028
395 TROPONIN INCREASED 21 0.0028
396 INFUSION SITE ERYTHEMA 23 0.0027
397 HYPOAESTHESIA ORAL 41 0.0027
398 ILLNESS 280 0.0027
399 OEDEMA 147 0.0027
400 IRON DEFICIENCY ANAEMIA 25 0.0027
401 EYE PRURITUS 91 0.0027
402 DISCOMFORT 165 0.0027
403 BLEPHAROSPASM 17 0.0027
404 PNEUMONIA 871 0.0027
405 SKIN BURNING SENSATION 192 0.0027
406 ANAPHYLACTIC REACTION 148 0.0027
407 EMPHYSEMA 27 0.0027
408 INFLAMMATION 138 0.0027
409 ERYTHEMA 549 0.0027
410 CHOKING 52 0.0027
411 EYELID PTOSIS 27 0.0027
412 DYSARTHRIA 100 0.0027
413 SQUAMOUS CELL CARCINOMA OF SKIN 16 0.0026
414 VITREOUS FLOATERS 26 0.0026
415 INFUSION SITE PAIN 34 0.0026
416 PRURITUS 1010 0.0026
417 ONYCHOCLASIS 18 0.0026
418 PNEUMONIA BACTERIAL 24 0.0026
419 TENDON DISORDER 17 0.0026
420 NIGHT SWEATS 84 0.0026
421 ANHEDONIA 68 0.0026
422 DRY EYE 128 0.0026
423 HAEMORRHAGIC STROKE 20 0.0026
424 FEELING OF BODY TEMPERATURE CHANGE 15 0.0026
425 WOUND INFECTION 28 0.0026
426 NOCTURIA 31 0.0026
427 BRAIN FOG 40 0.0025
428 SKIN MASS 17 0.0025
429 NEUROPATHY PERIPHERAL 241 0.0025
430 ODYNOPHAGIA 15 0.0025
431 OXYGEN SATURATION DECREASED 141 0.0025
432 SPINAL OSTEOARTHRITIS 22 0.0025
433 VIRAL INFECTION 83 0.0025
434 OCULAR DISCOMFORT 28 0.0025
435 GLAUCOMA 48 0.0025
436 RESTLESS LEGS SYNDROME 45 0.0025
437 HEADACHE 1544 0.0025
438 LIP SWELLING 82 0.0025
439 CELLULITIS 124 0.0025
440 DRY THROAT 25 0.0025
441 SKIN DISORDER 82 0.0025
442 POLYP 16 0.0024
443 ECONOMIC PROBLEM 37 0.0024
444 SKIN ULCER 63 0.0024
445 HYPOPHOSPHATAEMIA 18 0.0024
446 URINARY INCONTINENCE 72 0.0024
447 TENDON RUPTURE 30 0.0024
448 NERVE INJURY 27 0.0024
449 FOOT FRACTURE 46 0.0024
450 RIGHT VENTRICULAR FAILURE 17 0.0024
451 NEPHROLITHIASIS 111 0.0024
452 MENTAL DISORDER 105 0.0024
453 DRY SKIN 321 0.0024
454 MENSTRUATION DELAYED 26 0.0024
455 URINARY RETENTION 80 0.0024
456 POOR QUALITY DEVICE USED 24 0.0024
457 DEPRESSED MOOD 126 0.0024
458 TENDON PAIN 18 0.0024
459 ORAL PAIN 53 0.0024
460 RENAL PAIN 25 0.0024
461 HAEMATOMA 61 0.0024
462 PULMONARY ARTERIAL HYPERTENSION 34 0.0023
463 GASTROINTESTINAL INFECTION 21 0.0023
464 VITAMIN D DECREASED 20 0.0023
465 EYE SWELLING 87 0.0023
466 HELICOBACTER INFECTION 24 0.0023
467 MUSCLE SPASMS 428 0.0023
468 METASTASES TO CENTRAL NERVOUS SYSTEM 30 0.0023
469 PRESCRIBED OVERDOSE 45 0.0023
470 EYE HAEMORRHAGE 31 0.0023
471 BRONCHOPULMONARY ASPERGILLOSIS 18 0.0023
472 UPPER GASTROINTESTINAL HAEMORRHAGE 39 0.0023
473 LOCALISED INFECTION 56 0.0023
474 CHILLS 271 0.0023
475 HAEMORRHOIDS 45 0.0023
476 SENSITIVE SKIN 17 0.0023
477 OCULAR HYPERAEMIA 109 0.0023
478 ANXIETY 653 0.0023
479 MIGRAINE 219 0.0023
480 COVID-19 402 0.0023
481 FEELING DRUNK 17 0.0023
482 PARAESTHESIA ORAL 33 0.0023
483 TINNITUS 105 0.0023
484 MOUTH ULCERATION 48 0.0023
485 FURUNCLE 18 0.0023
486 BLOOD PRESSURE ABNORMAL 45 0.0023
487 OSTEOPOROSIS 93 0.0023
488 DIARRHOEA HAEMORRHAGIC 21 0.0022
489 PRODUCT USE IN UNAPPROVED INDICATION 556 0.0022
490 SOMNOLENCE 450 0.0022
491 RASH PAPULAR 50 0.0022
492 POLLAKIURIA 93 0.0022
493 PAIN OF SKIN 60 0.0022
494 DEPRESSION 507 0.0022
495 ARTHRITIS 175 0.0022
496 URTICARIA 372 0.0022
497 BLOOD GLUCOSE ABNORMAL 41 0.0022
498 LIPASE INCREASED 17 0.0022
499 PHARYNGITIS STREPTOCOCCAL 24 0.0022
500 COVID-19 PNEUMONIA 26 0.0022
501 EYE INFLAMMATION 21 0.0022
502 DRUG ERUPTION 39 0.0022
503 TREATMENT FAILURE 181 0.0022
504 NAIL DISORDER 19 0.0022
505 TRANSIENT ISCHAEMIC ATTACK 73 0.0022
506 PARAESTHESIA 338 0.0021
507 IRRITABLE BOWEL SYNDROME 46 0.0021
508 PALPITATIONS 251 0.0021
509 SKIN DISCOLOURATION 98 0.0021
510 ANKLE FRACTURE 33 0.0021
511 ANGINA PECTORIS 61 0.0021
512 TOOTH INFECTION 28 0.0021
513 THROAT IRRITATION 95 0.0021
514 MYASTHENIA GRAVIS 17 0.0021
515 FRUSTRATION TOLERANCE DECREASED 17 0.0021
516 WEIGHT FLUCTUATION 22 0.0021
517 HYPOKALAEMIA 97 0.0021
518 NEUTROPENIC SEPSIS 15 0.0021
519 EPISTAXIS 157 0.0021
520 INSOMNIA 558 0.0021
521 RIB FRACTURE 43 0.0021
522 PSYCHOLOGICAL TRAUMA 18 0.0021
523 INFUSION RELATED REACTION 138 0.0021
524 APHONIA 29 0.0021
525 ULCER 33 0.0021
526 DERMATITIS BULLOUS 15 0.0021
527 GENERAL PHYSICAL HEALTH DETERIORATION 239 0.0021
528 ELECTROLYTE IMBALANCE 24 0.0021
529 DIZZINESS POSTURAL 20 0.0021
530 HYPOAESTHESIA 308 0.0021
531 MUSCLE INJURY 17 0.0020
532 GROIN PAIN 18 0.0020
533 ORAL HERPES 40 0.0020
534 ORAL DISORDER 15 0.0020
535 POOR QUALITY SLEEP 44 0.0020
536 MYALGIA 347 0.0020
537 HEPATIC STEATOSIS 38 0.0020
538 EYE INFECTION 23 0.0020
539 AFFECTIVE DISORDER 16 0.0020
540 PERIPHERAL SWELLING 313 0.0020
541 HEART RATE INCREASED 201 0.0020
542 BACK INJURY 22 0.0020
543 CONTUSION 194 0.0020
544 HAEMATURIA 69 0.0020
545 ABSCESS 32 0.0020
546 COLITIS 76 0.0020
547 CATARACT 119 0.0020
548 CONDITION AGGRAVATED 607 0.0020
549 STOMATITIS 121 0.0020
550 PYREXIA 690 0.0020
551 METASTASES TO LUNG 23 0.0020
552 SUICIDAL IDEATION 182 0.0020
553 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 358 0.0020
554 PULMONARY EMBOLISM 188 0.0020
555 HYPERTENSIVE CRISIS 22 0.0020
556 MUSCULOSKELETAL DISCOMFORT 34 0.0020
557 PRODUCT PRESCRIBING ISSUE 43 0.0020
558 BACK DISORDER 32 0.0020
559 INTERVERTEBRAL DISC PROTRUSION 43 0.0020
560 ACUTE MYOCARDIAL INFARCTION 58 0.0020
561 PARALYSIS 28 0.0020
562 BLOOD PRESSURE INCREASED 299 0.0020
563 INFECTION 282 0.0019
564 VITAMIN D DEFICIENCY 19 0.0019
565 HEART RATE IRREGULAR 44 0.0019
566 THYROID DISORDER 30 0.0019
567 SWELLING 182 0.0019
568 NEUROLEPTIC MALIGNANT SYNDROME 23 0.0019
569 SYNCOPE 194 0.0019
570 HUNGER 27 0.0019
571 COELIAC DISEASE 19 0.0019
572 RASH 844 0.0019
573 INTENTIONAL DOSE OMISSION 55 0.0019
574 SCAR 33 0.0019
575 APNOEA 15 0.0019
576 LUNG INFILTRATION 17 0.0019
577 THROAT TIGHTNESS 52 0.0019
578 APHASIA 58 0.0019
579 GAIT INABILITY 64 0.0019
580 STAPHYLOCOCCAL INFECTION 63 0.0019
581 WEIGHT DECREASED 533 0.0019
582 LIMB DISCOMFORT 59 0.0019
583 FACIAL PAIN 17 0.0019
584 CANDIDA INFECTION 32 0.0019
585 GINGIVAL PAIN 15 0.0019
586 CHEST PAIN 349 0.0019
587 DIVERTICULITIS 52 0.0019
588 LUNG INFECTION 29 0.0019
589 INFLUENZA LIKE ILLNESS 153 0.0019
590 PARANOIA 32 0.0019
591 INTENTIONAL PRODUCT USE ISSUE 162 0.0018
592 TACHYCARDIA 164 0.0018
593 HERPES ZOSTER 106 0.0018
594 PRODUCT DOSE OMISSION ISSUE 538 0.0018
595 GASTROENTERITIS VIRAL 33 0.0018
596 BEDRIDDEN 24 0.0018
597 CYSTITIS 58 0.0018
598 MELAENA 40 0.0018
599 PRODUCT ODOUR ABNORMAL 19 0.0018
600 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
601 TRANSFUSION 19 0.0018
602 FOLLICULITIS 19 0.0018
603 INJECTION SITE DISCOMFORT 19 0.0018
604 LEUKAEMIA 17 0.0018
605 ATRIAL SEPTAL DEFECT 15 0.0018
606 RETCHING 38 0.0018
607 BACK PAIN 414 0.0018
608 DYSSTASIA 52 0.0018
609 FEBRILE NEUTROPENIA 118 0.0018
610 MENTAL IMPAIRMENT 43 0.0018
611 CHOLELITHIASIS 58 0.0018
612 HEART RATE DECREASED 62 0.0018
613 ABDOMINAL DISTENSION 184 0.0018
614 HOSPITALISATION 270 0.0018
615 VENTRICULAR TACHYCARDIA 29 0.0018
616 OEDEMA PERIPHERAL 214 0.0018
617 PHARYNGEAL OEDEMA 27 0.0018
618 TREMOR 291 0.0018
619 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
620 ARTHRALGIA 727 0.0017
621 CONSTIPATION 381 0.0017
622 MUSCLE STRAIN 15 0.0017
623 NERVE COMPRESSION 16 0.0017
624 THERAPY PARTIAL RESPONDER 27 0.0017
625 BLOOD CREATININE INCREASED 113 0.0017
626 PRODUCT DOSE OMISSION IN ERROR 49 0.0017
627 DEVICE DISLOCATION 75 0.0017
628 PRODUCT DISTRIBUTION ISSUE 16 0.0017
629 VERTIGO 105 0.0017
630 PAIN IN EXTREMITY 507 0.0017
631 MASS 24 0.0017
632 JOINT RANGE OF MOTION DECREASED 23 0.0017
633 ROTATOR CUFF SYNDROME 22 0.0017
634 MOVEMENT DISORDER 55 0.0017
635 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
636 THROMBOSIS 137 0.0017
637 NECK PAIN 95 0.0017
638 GENERALISED OEDEMA 21 0.0017
639 PERICARDIAL EFFUSION 39 0.0017
640 GINGIVAL BLEEDING 23 0.0017
641 NIGHTMARE 58 0.0017
642 THERAPEUTIC PRODUCT EFFECT DECREASED 75 0.0017
643 HYPERSOMNIA 48 0.0017
644 ANKYLOSING SPONDYLITIS 22 0.0017
645 PRODUCT AVAILABILITY ISSUE 38 0.0017
646 LETHARGY 96 0.0017
647 STEVENS-JOHNSON SYNDROME 37 0.0017
648 RASH MACULO-PAPULAR 37 0.0017
649 BRAIN OEDEMA 21 0.0017
650 THERAPEUTIC RESPONSE DECREASED 100 0.0016
651 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
652 C-REACTIVE PROTEIN INCREASED 60 0.0016
653 MUSCULAR WEAKNESS 187 0.0016
654 URINARY TRACT INFECTION 279 0.0016
655 PHOTOSENSITIVITY REACTION 27 0.0016
656 BLOOD CREATINE PHOSPHOKINASE INCREASED 47 0.0016
657 JOINT SWELLING 197 0.0016
658 INCREASED TENDENCY TO BRUISE 15 0.0016
659 CARDIOMEGALY 20 0.0016
660 MALAISE 706 0.0016
661 HYPERHIDROSIS 207 0.0016
662 OVARIAN CYST 16 0.0016
663 HYPONATRAEMIA 90 0.0016
664 CARDIAC FAILURE 128 0.0016
665 FLUID RETENTION 81 0.0016
666 MITRAL VALVE INCOMPETENCE 18 0.0016
667 APPLICATION SITE PAIN 35 0.0016
668 PAIN IN JAW 45 0.0016
669 LIVER FUNCTION TEST ABNORMAL 46 0.0016
670 MYOCARDIAL ISCHAEMIA 18 0.0016
671 MUSCLE ATROPHY 20 0.0016
672 CHOLECYSTECTOMY 18 0.0016
673 ALANINE AMINOTRANSFERASE INCREASED 96 0.0016
674 GLOSSODYNIA 35 0.0016
675 ABDOMINAL PAIN 361 0.0016
676 UVEITIS 21 0.0015
677 RHEUMATOID ARTHRITIS 175 0.0015
678 EYE DISCHARGE 16 0.0015
679 DENTAL CARIES 17 0.0015
680 DIZZINESS 765 0.0015
681 EYE IRRITATION 88 0.0015
682 TASTE DISORDER 31 0.0015
683 LYMPHOCYTE COUNT DECREASED 27 0.0015
684 BALANCE DISORDER 132 0.0015
685 FATIGUE 1188 0.0015
686 VISUAL IMPAIRMENT 187 0.0015
687 MOOD SWINGS 48 0.0015
688 ABDOMINAL PAIN UPPER 309 0.0015
689 SKIN REACTION 21 0.0015
690 BLOOD PRESSURE DECREASED 99 0.0015
691 INJECTION SITE SWELLING 114 0.0015
692 INJECTION SITE BRUISING 118 0.0015
693 WEIGHT INCREASED 331 0.0015
694 FEELING HOT 90 0.0015
695 NEUTROPHIL COUNT INCREASED 15 0.0015
696 DYSPHAGIA 139 0.0015
697 DIPLOPIA 38 0.0015
698 GAIT DISTURBANCE 280 0.0015
699 MULTIPLE FRACTURES 24 0.0015
700 PAIN 893 0.0015
701 BRADYCARDIA 77 0.0015
702 ANGER 49 0.0014
703 FALL 482 0.0014
704 SYNOVITIS 26 0.0014
705 FUNGAL INFECTION 48 0.0014
706 INJURY 101 0.0014
707 ARRHYTHMIA 68 0.0014
708 BLOOD SODIUM DECREASED 27 0.0014
709 PRODUCT PRESCRIBING ERROR 34 0.0014
710 ACCIDENT 17 0.0014
711 MUSCLE RIGIDITY 17 0.0014
712 RECTAL HAEMORRHAGE 61 0.0014
713 DRUG INTERACTION 225 0.0014
714 ACUTE KIDNEY INJURY 217 0.0014
715 GASTROINTESTINAL DISORDER 126 0.0014
716 SEROTONIN SYNDROME 27 0.0014
717 ALOPECIA 276 0.0014
718 THERAPEUTIC RESPONSE UNEXPECTED 63 0.0014
719 INJECTION SITE PRURITUS 94 0.0014
720 AGEUSIA 35 0.0014
721 DYSPEPSIA 138 0.0014
722 ASTHENIA 527 0.0014
723 RENAL FAILURE 186 0.0014
724 THIRST 25 0.0014
725 MYOCARDITIS 16 0.0014
726 THINKING ABNORMAL 26 0.0014
727 WOUND 39 0.0014
728 HAEMATOCHEZIA 77 0.0014
729 OFF LABEL USE 1221 0.0014
730 HYPOACUSIS 60 0.0014
731 MOOD ALTERED 38 0.0014
732 HOT FLUSH 105 0.0014
733 RESPIRATORY FAILURE 101 0.0014
734 EXPOSURE DURING PREGNANCY 86 0.0014
735 SMALL INTESTINAL OBSTRUCTION 17 0.0014
736 RENAL IMPAIRMENT 116 0.0014
737 MOBILITY DECREASED 99 0.0014
738 ANAEMIA 262 0.0014
739 RESTLESSNESS 50 0.0014
740 ABDOMINAL DISCOMFORT 229 0.0014
741 EYE PAIN 77 0.0014
742 LOSS OF CONSCIOUSNESS 174 0.0014
743 UPPER LIMB FRACTURE 27 0.0014
744 INTESTINAL OBSTRUCTION 51 0.0014
745 SURGERY 79 0.0013
746 VISION BLURRED 185 0.0013
747 MUSCLE TWITCHING 31 0.0013
748 INTENTIONAL PRODUCT MISUSE 117 0.0013
749 FREQUENT BOWEL MOVEMENTS 36 0.0013
750 GASTRITIS 35 0.0013
751 WHITE BLOOD CELL COUNT INCREASED 51 0.0013
752 HALLUCINATION 100 0.0013
753 DELIRIUM 46 0.0013
754 PALLOR 36 0.0013
755 FEELING ABNORMAL 317 0.0013
756 ANOREXIA 17 0.0013
757 ANAPHYLACTIC SHOCK 34 0.0013
758 SCIATICA 21 0.0013
759 EXPOSURE VIA SKIN CONTACT 34 0.0013
760 OSTEONECROSIS 43 0.0013
761 SEPSIS 146 0.0013
762 INSURANCE ISSUE 20 0.0013
763 DRY MOUTH 106 0.0013
764 RESPIRATORY DISTRESS 36 0.0013
765 SPINAL OPERATION 16 0.0013
766 PULMONARY OEDEMA 58 0.0013
767 PRODUCT DISPENSING ERROR 28 0.0013
768 DRUG EFFECT LESS THAN EXPECTED 19 0.0013
769 PHOTOPHOBIA 24 0.0013
770 KIDNEY INFECTION 25 0.0013
771 LEUKOCYTOSIS 23 0.0013
772 SINUS TACHYCARDIA 18 0.0013
773 BLOOD CHOLESTEROL INCREASED 59 0.0013
774 DISABILITY 25 0.0013
775 CHOLECYSTITIS 15 0.0013
776 HEPATIC ENZYME INCREASED 85 0.0012
777 ARTHROPATHY 69 0.0012
778 PRODUCT USE ISSUE 233 0.0012
779 HEMIPARESIS 21 0.0012
780 AGRANULOCYTOSIS 23 0.0012
781 DECREASED APPETITE 287 0.0012
782 NAUSEA 975 0.0012
783 DYSKINESIA 50 0.0012
784 DRUG INEFFECTIVE 1618 0.0012
785 HAEMOGLOBIN DECREASED 126 0.0012
786 DEVICE MALFUNCTION 86 0.0012
787 INJECTION SITE URTICARIA 30 0.0012
788 COGNITIVE DISORDER 57 0.0012
789 COORDINATION ABNORMAL 17 0.0012
790 IMPAIRED HEALING 40 0.0012
791 NERVOUS SYSTEM DISORDER 38 0.0012
792 DIARRHOEA 785 0.0012
793 TOOTHACHE 22 0.0012
794 HYPOTENSION 243 0.0012
795 COLITIS ULCERATIVE 54 0.0012
796 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
797 CARDIAC FAILURE CONGESTIVE 97 0.0012
798 FLATULENCE 68 0.0012
799 LOWER LIMB FRACTURE 23 0.0012
800 DIABETES MELLITUS 91 0.0012
801 ADVERSE EVENT 109 0.0012
802 TACHYPNOEA 16 0.0012
803 CIRCULATORY COLLAPSE 20 0.0012
804 HYPERTHYROIDISM 17 0.0012
805 LIVER DISORDER 52 0.0012
806 DISTURBANCE IN ATTENTION 63 0.0012
807 VOMITING 547 0.0012
808 SKIN CANCER 25 0.0012
809 OSTEOMYELITIS 21 0.0012
810 MANIA 19 0.0012
811 DEAFNESS 30 0.0011
812 EPILEPSY 35 0.0011
813 CYANOSIS 18 0.0011
814 EMOTIONAL DISTRESS 138 0.0011
815 DEEP VEIN THROMBOSIS 74 0.0011
816 HEAD INJURY 36 0.0011
817 ABNORMAL BEHAVIOUR 45 0.0011
818 SEIZURE 131 0.0011
819 CONFUSIONAL STATE 183 0.0011
820 CONTRAINDICATED PRODUCT ADMINISTERED 34 0.0011
821 HYPOCALCAEMIA 21 0.0011
822 HAEMATOCRIT DECREASED 22 0.0011
823 PNEUMONITIS 30 0.0011
824 MUSCULOSKELETAL CHEST PAIN 17 0.0011
825 WITHDRAWAL SYNDROME 46 0.0011
826 POST PROCEDURAL COMPLICATION 21 0.0011
827 ACUTE RESPIRATORY FAILURE 21 0.0011
828 MUSCULOSKELETAL PAIN 57 0.0011
829 ERUCTATION 21 0.0011
830 RED BLOOD CELL COUNT DECREASED 31 0.0011
831 RASH GENERALISED 28 0.0011
832 NERVOUSNESS 56 0.0011
833 SKIN IRRITATION 49 0.0011
834 INJECTION SITE WARMTH 22 0.0011
835 SPEECH DISORDER 56 0.0011
836 IRRITABILITY 64 0.0011
837 TREATMENT NONCOMPLIANCE 58 0.0011
838 UNDERDOSE 77 0.0011
839 CYTOKINE RELEASE SYNDROME 21 0.0010
840 FLUSHING 106 0.0010
841 SYSTEMIC LUPUS ERYTHEMATOSUS 37 0.0010
842 PRODUCT PHYSICAL ISSUE 21 0.0010
843 JAUNDICE 28 0.0010
844 FEEDING DISORDER 21 0.0010
845 EYE DISORDER 34 0.0010
846 BLOOD POTASSIUM DECREASED 31 0.0010
847 HAEMATEMESIS 26 0.0010
848 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
849 PRURITUS GENERALISED 22 0.0010
850 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
851 PERICARDITIS 17 0.0010
852 SEPTIC SHOCK 44 0.0010
853 MENTAL STATUS CHANGES 28 0.0010
854 PULMONARY HYPERTENSION 21 0.0010
855 MEMORY IMPAIRMENT 138 0.0010
856 HIP FRACTURE 32 0.0010
857 MUCOSAL INFLAMMATION 26 0.0010
858 TOOTH DISORDER 22 0.0010
859 HEPATOTOXICITY 22 0.0010
860 BONE DISORDER 18 0.0010
861 INJECTION SITE PAIN 301 0.0010
862 ADVERSE DRUG REACTION 88 0.0010
863 HIP ARTHROPLASTY 15 0.0010
864 AGGRESSION 49 0.0010
865 LIVER INJURY 24 0.0010
866 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
867 DEVICE RELATED INFECTION 15 0.0010
868 INJECTION SITE MASS 36 0.0010
869 AMNESIA 63 0.0010
870 INJECTION SITE ERYTHEMA 120 0.0010
871 DEHYDRATION 129 0.0010
872 PANCYTOPENIA 54 0.0010
873 COLD SWEAT 17 0.0010
874 CRYING 35 0.0010
875 BONE DENSITY DECREASED 30 0.0010
876 ROAD TRAFFIC ACCIDENT 40 0.0010
877 ILL-DEFINED DISORDER 58 0.0010
878 UNEVALUABLE EVENT 72 0.0010
879 CEREBRAL HAEMORRHAGE 34 0.0009
880 PRESYNCOPE 23 0.0009
881 ERECTILE DYSFUNCTION 24 0.0009
882 DEMENTIA 26 0.0009
883 UNRESPONSIVE TO STIMULI 24 0.0009
884 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 17 0.0009
885 MUSCLE TIGHTNESS 15 0.0009
886 AGITATION 67 0.0009
887 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
888 HYPOGLYCAEMIA 44 0.0009
889 FEELING JITTERY 17 0.0009
890 INCORRECT DOSE ADMINISTERED 203 0.0009
891 DYSGEUSIA 66 0.0009
892 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
893 RENAL INJURY 26 0.0009
894 GASTRIC DISORDER 30 0.0009
895 INJECTION SITE REACTION 60 0.0009
896 ABDOMINAL PAIN LOWER 22 0.0009
897 THERAPY NON-RESPONDER 39 0.0009
898 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
899 BONE PAIN 50 0.0009
900 HALLUCINATION, VISUAL 18 0.0009
901 SPINAL FRACTURE 17 0.0008
902 NO ADVERSE EVENT 153 0.0008
903 CHROMATURIA 19 0.0008
904 RHABDOMYOLYSIS 35 0.0008
905 ABNORMAL DREAMS 23 0.0008
906 PELVIC PAIN 15 0.0008
907 ACNE 62 0.0008
908 DISORIENTATION 32 0.0008
909 SEDATION 21 0.0008
910 HEPATIC CIRRHOSIS 15 0.0008
911 DRUG DEPENDENCE 128 0.0008
912 FULL BLOOD COUNT DECREASED 16 0.0008
913 FRACTURE 15 0.0008
914 PRODUCT ADMINISTRATION ERROR 16 0.0008
915 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
916 THROMBOCYTOPENIA 88 0.0008
917 DRUG RESISTANCE 20 0.0008
918 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
919 WHITE BLOOD CELL COUNT DECREASED 83 0.0008
920 DRUG-INDUCED LIVER INJURY 24 0.0008
921 APPLICATION SITE ERYTHEMA 20 0.0008
922 JOINT STIFFNESS 20 0.0008
923 NEUTROPHIL COUNT DECREASED 31 0.0008
924 THERAPY INTERRUPTED 54 0.0008
925 DISEASE PROGRESSION 89 0.0008
926 INJECTION SITE HAEMORRHAGE 60 0.0008
927 INJECTION SITE RASH 23 0.0007
928 IMPAIRED WORK ABILITY 16 0.0007
929 CARDIOVASCULAR DISORDER 19 0.0007
930 HYPOPHAGIA 19 0.0007
931 THERAPY CESSATION 38 0.0007
932 BLINDNESS 30 0.0007
933 CEREBROVASCULAR ACCIDENT 124 0.0007
934 ELECTROCARDIOGRAM QT PROLONGED 26 0.0007
935 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
936 PANCREATITIS ACUTE 16 0.0007
937 PSYCHOTIC DISORDER 21 0.0007
938 HAEMORRHAGE 74 0.0007
939 APPLICATION SITE PRURITUS 16 0.0007
940 EATING DISORDER 15 0.0007
941 BLOOD BILIRUBIN INCREASED 19 0.0007
942 PANCREATITIS 37 0.0007
943 ACCIDENTAL EXPOSURE TO PRODUCT 72 0.0007
944 FAECES DISCOLOURED 15 0.0007
945 NEUTROPENIA 94 0.0007
946 NEEDLE ISSUE 20 0.0007
947 EXPIRED PRODUCT ADMINISTERED 22 0.0007
948 PRODUCT DOSE OMISSION 43 0.0007
949 PLATELET COUNT DECREASED 70 0.0007
950 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
951 NEOPLASM MALIGNANT 43 0.0006
952 RENAL FAILURE ACUTE 27 0.0006
953 MENSTRUATION IRREGULAR 17 0.0006
954 HEPATITIS 16 0.0006
955 INTERSTITIAL LUNG DISEASE 30 0.0006
956 PRODUCT SUBSTITUTION ISSUE 35 0.0006
957 ABORTION SPONTANEOUS 24 0.0006
958 MULTIPLE SCLEROSIS 28 0.0006
959 GYNAECOMASTIA 18 0.0006
960 LABORATORY TEST ABNORMAL 17 0.0006
961 HYPERKALAEMIA 20 0.0006
962 EXTRA DOSE ADMINISTERED 23 0.0006
963 PLASMA CELL MYELOMA 22 0.0006
964 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
965 BREAST CANCER 50 0.0005
966 CARDIAC ARREST 43 0.0005
967 PRODUCT QUALITY ISSUE 70 0.0005
968 ASCITES 15 0.0005
969 LACTIC ACIDOSIS 16 0.0005
970 HEPATIC FUNCTION ABNORMAL 18 0.0005
971 ACCIDENTAL OVERDOSE 17 0.0005
972 LEUKOPENIA 22 0.0004
973 LUNG NEOPLASM MALIGNANT 18 0.0004
974 VAGINAL HAEMORRHAGE 19 0.0004
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87 0.0004
976 SUICIDE ATTEMPT 26 0.0004
977 MYOCARDIAL INFARCTION 73 0.0004
978 MYELOSUPPRESSION 15 0.0004
979 DEVICE LEAKAGE 18 0.0004
980 OVERDOSE 88 0.0004
981 BLOOD GLUCOSE INCREASED 76 0.0004
982 MULTIPLE SCLEROSIS RELAPSE 27 0.0004
983 MALIGNANT NEOPLASM PROGRESSION 39 0.0004
984 DEVICE ISSUE 33 0.0004
985 BLOOD GLUCOSE DECREASED 17 0.0004
986 DRUG EFFECT DECREASED 19 0.0004
987 CONVULSION 20 0.0003
988 DEATH 301 0.0003
989 TOXICITY TO VARIOUS AGENTS 58 0.0003
990 PRODUCT STORAGE ERROR 25 0.0003
991 DRUG DOSE OMISSION 34 0.0002
992 DRUG WITHDRAWAL SYNDROME 16 0.0002